Exchange Capital Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.94M | Sell |
21,301
-6,161
| -22% | -$596K | 0.29% | 92 |
|
|
2025
Q1 | $3.11M | Buy |
27,462
+260
| +1% | +$27.8K | 0.5% | 63 |
|
|
2024
Q4 | $2.87M | Sell |
27,202
-191
| -0.7% | -$20.5K | 0.46% | 69 |
|
|
2024
Q3 | $2.96M | Sell |
27,393
-636
| -2% | -$69.4K | 0.47% | 70 |
|
|
2024
Q2 | $3.04M | Sell |
28,029
-542
| -2% | -$63.9K | 0.5% | 66 |
|
|
2024
Q1 | $3.77M | Buy |
28,571
+5,614
| +24% | +$701K | 0.61% | 53 |
|
|
2023
Q4 | $2.79M | Sell |
22,957
-738
| -3% | -$82.3K | 0.5% | 64 |
|
|
2023
Q3 | $2.66M | Buy |
23,695
+2,225
| +10% | +$283K | 0.5% | 65 |
|
|
2023
Q2 | $3.13M | Buy |
21,470
+96
| +0.4% | +$13K | 0.58% | 56 |
|
|
2023
Q1 | $2.76M | Buy |
21,374
+1,947
| +10% | +$244K | 0.56% | 64 |
|
|
2022
Q4 | $2.48M | Sell |
19,427
-95
| -0.5% | -$11K | 0.54% | 67 |
|
|
2022
Q3 | $2.04M | Sell |
19,522
-282
| -1% | -$30.9K | 0.47% | 72 |
|
|
2022
Q2 | $2.08M | Sell |
19,804
-230
| -1% | -$27.3K | 0.45% | 74 |
|
|
2022
Q1 | $2.56M | Buy |
20,034
+2,281
| +13% | +$275K | 0.48% | 70 |
|
|
2021
Q4 | $2.19M | Buy |
17,753
+480
| +3% | +$62.8K | 0.4% | 80 |
|
|
2021
Q3 | $2.45M | Buy |
17,273
+2,281
| +15% | +$336K | 0.48% | 67 |
|
|
2021
Q2 | $2.34M | Sell |
14,992
-15
| -0.1% | -$2.43K | 0.45% | 72 |
|
|
2021
Q1 | $2.33M | Sell |
15,007
-39
| -0.3% | -$6.04K | 0.48% | 68 |
|
|
2020
Q4 | $2.25M | Sell |
15,046
-36
| -0.2% | -$5.08K | 0.5% | 65 |
|
|
2020
Q3 | $1.99M | Sell |
15,082
-730
| -5% | -$95.4K | 0.5% | 64 |
|
|
2020
Q2 | $1.83M | Sell |
15,812
-17,825
| -53% | -$2.05M | 0.51% | 62 |
|
|
2020
Q1 | $3.3M | Buy |
33,637
+162
| +0.5% | +$21.2K | 1.08% | 40 |
|
|
2019
Q4 | $4.87M | Sell |
33,475
-617
| -2% | -$85.2K | 1.25% | 27 |
|
|
2019
Q3 | $4.54M | Buy |
34,092
+98
| +0.3% | +$12.7K | 1.2% | 31 |
|
|
2019
Q2 | $3.89M | Buy |
33,994
+2,278
| +7% | +$267K | 1.04% | 39 |
|
|
2019
Q1 | $3.93M | Buy |
31,716
+14,993
| +90% | +$1.7M | 1.1% | 32 |
|
|
2018
Q4 | $1.68M | Buy |
16,723
+1,169
| +8% | +$131K | 0.55% | 66 |
|
|
2018
Q3 | $1.99M | Buy |
+15,554
| New | +$1.85M | 0.58% | 62 |
|
|
2018
Q2 | – | Sell |
-8,792
| Closed | -$931K | – | 272 |
|
|
2018
Q1 | $931K | Buy |
8,792
+1,091
| +14% | +$127K | 0.29% | 82 |
|
|
2017
Q4 | $902K | Buy |
7,701
+2,411
| +46% | +$273K | 0.28% | 80 |
|
|
2017
Q3 | $601K | Buy |
5,290
+5,135
| +3,313% | +$593K | 0.2% | 95 |
|
|
2017
Q2 | $19K | Hold |
155
| – | – | 0.01% | 161 |
|
|
2017
Q1 | $18K | Hold |
155
| – | – | 0.01% | 148 |
|
|
2016
Q4 | $15K | Hold |
155
| – | – | 0.01% | 137 |
|
|
2016
Q3 | $20K | Hold |
155
| – | – | 0.01% | 142 |
|
|
2016
Q2 | $18K | Buy |
+155
| New | +$17.5K | 0.01% | 133 |
|
Other funds holding ZBH
Exchange Capital Management's ZBH Position: Q2 2025 in Review
Exchange Capital Management reduced its Zimmer Biomet (ZBH) stake by 22% in Q2 2025, selling an estimated $596K and leaving 21,301 shares worth $1.94M. The position accounts for 0.29% of the portfolio, ranked #92.
Exchange Capital Management first reported a position in ZBH in Q2 2016 and has held it in 36 quarters since. The position peaked at $4.87M in Q4 2019. 934 funds tracked by Wall St. Rank hold ZBH as of Q2 2025.
- Exchange Capital Management held 21,301 shares of Zimmer Biomet worth $1.94M as of Q2 2025.
- Exchange Capital Management sold 6,161 Zimmer Biomet shares in Q2 2025, an estimated $596K.
- Zimmer Biomet made up 0.29% of Exchange Capital Management's portfolio in Q2 2025, its #92 holding.
- Exchange Capital Management first reported a position in Zimmer Biomet in Q2 2016 and has held it in 36 quarters since.
- Exchange Capital Management's Zimmer Biomet position peaked at $4.87M in Q4 2019.
- 934 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2025.
Based on Exchange Capital Management's 13F filing for Q2 2025, filed 21 Jul 2025.